|

MDMA Clinical Trials

2 actively recruiting trials across 1 location

Also known as: 3,4-methylenedioxymethamphetamine (MDMA)

Pipeline

Phase 2: 1

Top Sponsors

  • University Hospital, Basel, Switzerland1
  • Sunstone Medical1

Indications

  • Central Diabetes Insipidus1
  • Adjustment Disorders1
  • Diabetes1
  • Cancer1

Other1 trial

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
N/A

Rockville, Maryland1 trial

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Sunstone Medical, PC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.